ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard ...

Veteran drug developer and prior CMO from Novartis AG gene therapies brings decades of clinical experience including long tenure as Global Lead for secukinumab, which he advanced from early development

Related Keywords

United Kingdom ,Los Angeles ,Tyler Marciniak ,Hidradenitis Suppurativa ,Nasdaq ,University Of Zimbabwe ,Royal College Of Physicians United Kingdom ,Godfrey Huggins School Of Medicine ,Senior Leadership Team ,Exchange Commission ,Global Lead ,Psoriatic Arthritis ,Axial Spondyloarthritis ,Senior Vice President ,Senior Leadership ,Chief Medical Officer ,Gene Therapy ,Royal College ,Physicians United Kingdom ,Godfrey Huggins School ,San Francisco Bay ,Quarterly Report ,Investor Relations ,Region ,